Crimean-Congo haemorrhagic fever.

Area of Science:

• Virology
• Epidemiology
• Immunology

Background:

• Crimean-Congo hemorrhagic fever (CCHF) is a widespread arbovirosis caused by a nairovirus, prevalent in Africa, Europe, the Middle East, and Asia.
• The disease is transmitted by Hyalomma ticks and affects humans severely, often with a high mortality rate, presenting symptoms like fever, dizziness, headache, vomiting, and hemorrhages.

Purpose of the Study:

• To summarize the current understanding of CCHF, including its epidemiology, pathogenesis, diagnosis, and treatment.
• To highlight the need for further research into efficient vaccines and antivirals for CCHF.

Main Methods:

• Review of existing literature on CCHF.
• Analysis of pathogenesis studies, particularly those involving interferon-receptor-deficient mice.
• Summary of diagnostic techniques such as RT-PCR, ELISA, and immunofluorescence.
• Overview of past vaccine trials and current treatment recommendations.

Main Results:

• The interferon response is crucial for controlling CCHF virus propagation and disease protection.
• Current diagnostic methods include RT-PCR for viral detection and serological assays for antibodies.
• A formalin-inactivated vaccine used in the past has unproven efficacy.
• Ribavirin is recommended for early treatment, as per WHO guidelines.

Conclusions:

• Despite progress, significant gaps remain in understanding CCHF pathogenesis and epidemiology.
• There is an urgent need for the development of effective vaccines and antiviral therapies to combat CCHF.